BioStem Technologies, Inc.BSEM

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$4.14
Market cap
$69.0M
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
-18.5%
Net margin
—
Revenue growth
—
Debt / equity
0.00x

What BioStem Technologies, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year20242025

More on BSEM.

Figures from BioStem Technologies, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.